CEV CEV
Company Profile ↓Company Overview
CEV (CEV) is a publicly traded company listed on with a market capitalization of $72.73M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Nov 2025 Revenue of $418.33K (-92.9% YoY); net profit $5.48K.
- Trailing 12 Months Year-on-year growth — revenue -92.9%, earnings -99.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -92.93% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -99.90% |
Stock Price Performance
| 1 Year: | +8.24% |
| 6 Months: | +3.22% |
| 3 Months: | +3.45% |
| 1 Month: | +4.00% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)54.31 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|
| Revenue | - | -17.18M | 2.90M | 5.92M | 418.33K |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 476.12K | 405.78K | 442.56K | 412.84K |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 848.09K | 1.45M | 1.15M | 1.07M |
| Pretax Income | - | -17.66M | 2.50M | 5.48M | 5.48K |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -17.66M | 2.50M | 5.48M | 5.48K |
| Diluted EPS | 0.52 | -2.48 | 0.36 | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|
| Total Assets | 126.19M | 114.11M | 109.95M | 119.33M |
| Current Assets | - | - | - | - |
| Cash & Equivalents | 1.84M | 394.32K | 112.66K | 88.69K |
| Inventory | - | - | - | - |
| Receivables | 1.23M | 1.42M | 1.09M | 1.43M |
| Total Liabilities | 44.24M | 32.69M | 26.88M | 40.48M |
| Current Liabilities | - | - | - | - |
| Long Term Debt | - | - | - | - |
| Total Debt | 43.82M | 32.29M | 26.42M | 37.67M |
| Total Equity | 81.95M | 81.42M | 83.07M | 78.85M |
| Shares Outstanding | 7.03M | 7.03M | 7.03M | 7.03M |
Cash Flows (Annual)
Figures in USD.
| Metric | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 21.71M | 13.12M | 9.43M | -7.04M |
| Investing Cash Flow | - | - | - | - |
| Financing Cash Flow | -20.26M | -14.57M | -9.71M | 7.02M |
| Capital Expenditure | - | - | - | - |
| Free Cash Flow | 21.71M | 13.12M | 9.43M | -7.04M |
| Net Change in Cash | 1.45M | -1.45M | -281.67K | -23.97K |
Ratios (Annual)
Figures in %.
| Metric | Nov 2021 | Nov 2022 | Nov 2023 | Nov 2024 | Nov 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 102.8% | 86.0% | 92.5% | 1.3% |
| ROE % | - | -21.5% | 3.1% | 6.6% | 0.0% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CEV
(CEV) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxORl9NdW1xTGlJRWZjMEhUbzI1RkpuN3VSTDdhc21fa2xjdjR6NXRnOWFBNWpsal9MSnRFei1vb2d1Uk5vYmd0c0NGMThEeVRVaU96Z0lxY1VqQU9PWEFxeE5yODVKSXZvMi1sNHBLUzRNMHM5TXZMcGtXUkROTUY3SHlnYzdWOW9vQVJmTW…
Merck's two-drug bladder cancer treatment is EU-approved whether or not standard chemotherapy is an option. - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxORS1TcW1oNVpkcWlMYXdtNkRaNFBfMTFIckNmM05IN3ZXcWtnSjdwQ1lsWUNRUFhXQkQyZDY4NUlZUk5nQmttNW95dGZIYnl1WkVaVkFnWm1kQ05IdEY1eWUya1RidF9aVllyNVhYR1B1NnNjMWZHcHBkc2RHdHdTV3NvNERIckhTVFVVVn…
Stock recommendations for 3 September from MarketSmith India - TradingView
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQdDlmd3dIR19iTTFuVm12dGxkQ1JxNHZhZHVkZzNmRGJ2amNKbGZBa3lKWl9tME1KLUJqZ3pLU3lFMGdJV0NueXE1c05EZnNaRzU2TmFjTmtiOTloSmxBeFhxMXRpRGRxSUI2VTRORnVqNlllMmg2Rlg1WlBVaTk3X3pxUzFJOG01OExzUH…
(AMEX: CEV) Share Price, CEV Stock News, CEV Share Price & Updates - kalkine.ca
<a href="https://news.google.com/rss/articles/CBMiTEFVX3lxTE5EZ081alRtNVBRSmJPS0tVN0RwbzUtLUNzMGxBcGJ0dFo5V1ZwSkJJRnNlOHB1ZGJsMG0yUWM5MXlOaGNLMWFzRWhyMzA?oc=5" target="_blank">(AMEX: CEV) Share Price, CEV Stock News, CEV Share Price & Updat…
Pfizer Beats Q2 Estimates with $15 Billion Quarter, Raises Outlook, and Stock Rises as Eliquis and Padcev Lead Growth - BBN Times
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxNVXJ3WjMwOGxqSHFpZWtjeV9tV2tUUjgySzdjNDVXYURWTVMyY1ktblE1N1czbUMzRkRDbVpUUVpoQXk1OFlvOF9yM2Jic3hsNlMxYmdPUWE0bzlETWM1bnQ4ejNVMjZucGNzRERQdktjSmdaWEZUcDY5Ujlob2Y0a2RJLTR2UzRpY1Nydk…
Technical Reactions to CEV Trends in Macro Strategies - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNNjNtaG92VDZDMVZyWS03S1FOeU15UXhPT3VTekJqNmRORGpKSjBSSFBsNjR6THVnQkFGM2NrV0tfMEstQWN5YmN4VkZMNVh2d2dXbURvR29pNXJhSFVVajJMT0JsRGMwYlFYUW1uZHJtVGJMczdNakVjbUFHdDNjbG1iSDFtVXFPNlpzR2…
CEV — Frequently Asked Questions
What is the current share price of CEV?
As of 2026-10-23 16:27 PDT, CEV trades at $10.34 on NASDAQ/NYSE. Its 52-week range is $9.53 to $10.74.
What is the market capitalisation of CEV?
CEV has a market capitalisation of $72.73M on NASDAQ/NYSE.
What is the P/E ratio of CEV?
CEV trades at a trailing price-to-earnings (P/E) ratio of 28.64. Its price-to-book (P/B) ratio is 0.92.
What is the return on equity (ROE) of CEV?
CEV has a return on equity (ROE) of 0.01%.
Is CEV a good stock to buy?
This page provides a data-driven analysis of CEV, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.